Church & Dwight (CHD) is under close monitoring by investors despite the decision to sell VitaFusion and L’il Critters Brands. This sale is anticipated to efficiently optimize the company's core potential. Amid the stock price fluctuation, some see CHD as undervalued after its recent share price slump. Despite this, robust Q3 earnings and revenue figures and an improved sales outlook go against bearish growth narratives. This strong financial performance was driven by upgraded estimates and CHD surpassing expectations.
Citi Research notably upgraded CHD, and
Argus Research maintained its buy recommendation. Despite these promising developments, elements such as recent insider trading, hedge fund activity, and the overall volatility of the consumer defensive sector have somewhat clouded CHD's market performance. Nevertheless, seasoned stockholders like
Thrivent Financial for Lutherans continue to bolster their stakes, indicating sustained faith in the stock’s potential. Also, CHD is earmarked to share its growth strategy at the Barclays Conference 2025.
Church Dwight CHD News Analytics from Tue, 04 Mar 2025 08:00:00 GMT to Sat, 03 Jan 2026 03:44:12 GMT -
Rating 7
- Innovation 3
- Information 7
- Rumor -2
